Product NDC: | 60432-616 |
Proprietary Name: | Lithium Hydroxide Monohydrate |
Non Proprietary Name: | Lithium Hydroxide Monohydrate |
Active Ingredient(s): | 8 meq/5mL & nbsp; Lithium Hydroxide Monohydrate |
Administration Route(s): | ORAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60432-616 |
Labeler Name: | Morton Grove Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA070755 |
Marketing Category: | ANDA |
Start Marketing Date: | 19860521 |
Package NDC: | 60432-616-16 |
Package Description: | 473 mL in 1 BOTTLE (60432-616-16) |
NDC Code | 60432-616-16 |
Proprietary Name | Lithium Hydroxide Monohydrate |
Package Description | 473 mL in 1 BOTTLE (60432-616-16) |
Product NDC | 60432-616 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Lithium Hydroxide Monohydrate |
Dosage Form Name | SOLUTION |
Route Name | ORAL |
Start Marketing Date | 19860521 |
Marketing Category Name | ANDA |
Labeler Name | Morton Grove Pharmaceuticals, Inc. |
Substance Name | LITHIUM HYDROXIDE MONOHYDRATE |
Strength Number | 8 |
Strength Unit | meq/5mL |
Pharmaceutical Classes | Mood Stabilizer [EPC] |